Tumour mutational burden as a biomarker in patients with mismatch repair deficient/microsatellite instability-high metastatic colorectal cancer treated with immune checkpoint inhibitors
European Journal of Cancer · 2023-07 · 187 · 15-24
DOI: 10.1016/j.ejca.2023.03.029 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Cancer, 2023-07. Verfasst von Paolo Manca und 19 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy. Electronic address: https://twitter.com/@paomanca. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Colonic Neoplasms. Die Arbeit wurde bisher 68-mal zitiert (Crossref) und nennt 38 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy. Electronic address: https://twitter.com/@paomanca.
- Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
- Department of Medical Oncology 1, Veneto Institute of Oncology IOV - IRCCS, Padua, Italy.
- Unit of Clinical Epidemiology and Trial Organization, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
- Azienda Ospedaliero-Universitaria Pisana, Pisa, Italy; Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Pisa, Italy.
- Department of Medical Oncology 1, Veneto Institute of Oncology IOV - IRCCS, Padua, Italy; Department of Surgery, Oncology and Gastroenterology, University of Padua, Padua, Italy.
Zitieren
APA
Manca, P., Corti, F., Intini, R., Mazzoli, G., Miceli, R., Germani, M. M., Bergamo, F., Ambrosini, M., Cristarella, E., Cerantola, R., Boccaccio, C., Ricagno, G., Ghelardi, F., Randon, G., Leoncini, G., Milione, M., Fassan, M., Cremolini, C., Lonardi, S., & Pietrantonio, F. (2023). Tumour mutational burden as a biomarker in patients with mismatch repair deficient/microsatellite instability-high metastatic colorectal cancer treated with immune checkpoint inhibitors. European Journal of Cancer, 187, 15-24. https://doi.org/10.1016/j.ejca.2023.03.029
Vancouver
Manca P, Corti F, Intini R, Mazzoli G, Miceli R, Germani MM, et al. Tumour mutational burden as a biomarker in patients with mismatch repair deficient/microsatellite instability-high metastatic colorectal cancer treated with immune checkpoint inhibitors. European Journal of Cancer. 2023;187:15-24. doi:10.1016/j.ejca.2023.03.029
BibTeX
@article{Manca2023,
author = {Manca, Paolo and Corti, Francesca and Intini, Rossana and Mazzoli, Giacomo and Miceli, Rosalba and Germani, Marco Maria and Bergamo, Francesca and Ambrosini, Margherita and Cristarella, Eleonora and Cerantola, Riccardo and Boccaccio, Chiara and Ricagno, Gianmarco and Ghelardi, Filippo and Randon, Giovanni and Leoncini, Giuseppe and Milione, Massimo and Fassan, Matteo and Cremolini, Chiara and Lonardi, Sara and Pietrantonio, Filippo},
title = {Tumour mutational burden as a biomarker in patients with mismatch repair deficient/microsatellite instability-high metastatic colorectal cancer treated with immune checkpoint inhibitors},
journal = {European Journal of Cancer},
year = {2023},
volume = {187},
pages = {15--24},
doi = {10.1016/j.ejca.2023.03.029}
}
EUVIMED